Intel (INTC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Intel stock at a glance Intel (INTC) is back in focus for many investors as its shares trade around $43.10, with mixed recent returns that include a small gain year to date but declines over the past ...

Investors were looking for signs that its momentum could carry over into 2026, but Intel's shares dropped by 6.5% in February, showing how quickly confidence can shift.

Intel (NASDAQ: INTC) stock is falling in Tuesday's trading. The company's share price was down 4.9% as of 1:25 p.m. ET, and the S&P 500 and Nasdaq Composite had fallen 1.3% and 1.2%, respectively.

A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira. Granted, it was the top-selling drug in the world at the time. But despite the 130 patents it ...

In equity markets, the most compelling opportunities often emerge where accessibility meets strong market participation.

Summary: At the start of 2026, 24/7 Wall St. Analyst and AI Investor Podcast co-host, Eric Bleeker, said that Intel was one stock that was really standing out to him as a potential buy. Bleeker ...

Hycroft Mining stock rose 35% in February, as gold and silver prices rebounded. The company could theoretically benefit from rising metal prices, but it doesn't currently operate its mine. The stock ...

Learn when to sell or hold stocks based on risk tolerance, market conditions, and personal financial goals. Make informed decisions to optimize your investment strategy.

Intel (INTC) closed the most recent trading day at $43.10, moving -5.27% from the previous trading session. This change lagged the S&P 500's 0.94% loss on the day. At the same time, the Dow lost ...

There’s a little-known hedge fund on Wall Street that has been making a splash. It is Ratan Capital Management, run […] ...

Intel Corporation (NASDAQ:INTC) is one of the stocks that should double in 3 years. On March 5, a bipartisan group of US ...